Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Jiawei Huoxiang Zhengqi Wan is a Traditional Chinese Medicine (TCM) formulation developed and manufactured by Zhongshan Shaxi Chinese Medicine Factory. It is a modified version of the classic Huoxiang Zhengqi formula, specifically enhanced to treat patterns of summer heat-dampness and exterior wind-cold with interior dampness stagnation. Clinically, it is primarily indicated for gastrointestinal flu, characterized by symptoms such as headache, dizziness, chest oppression, abdominal distension, nausea, vomiting, and diarrhea. The formulation consists of a complex blend of herbal ingredients, including *Agastache rugosa*, *Perilla frutescens*, *Angelica dahurica*, and *Magnolia officinalis*. Its therapeutic action is characterized by inducing diaphoresis to relieve exterior symptoms, resolving dampness to transform turbidity, and regulating the qi of the middle jiao to harmonize the stomach and spleen.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on jiawei huoxiang zhengqi wan.